Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O4RB
|
|||
Former ID |
DIB016499
|
|||
Drug Name |
DdRNAi therapy rHIV7-shl-TAR-CCR5RZ, stem cells
|
|||
Synonyms |
BLT-HIV; Lentiviral vector delivered DNA-directed RNAi therapeutic (HIV infection), Benitec; RHIV7-shl-TAR-CCR5RZ; T-cell therapy (HIV infection), Benitec; Lentiviral vector delivered DNA-directed RNAi therapeutic (HIV-associated lymphoma), Benitec; DdRNAi therapy (rHIV7-shl-TAR-CCR5RZ, T-cells, HIV), Benitec; DdRNAi therapy (rHIV7-shl-TAR-CCR5RZ, stem cells, HIV/lymphoma), Benitec
Click to Show/Hide
|
|||
Drug Type |
RNAi therapeutics
|
|||
Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1/2 | [1] | |
Company |
Benitec Ltd
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | CCR5 messenger RNA (CCR5 mRNA) | Target Info | . | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
Endocytosis | ||||
Toxoplasmosis | ||||
Viral carcinogenesis | ||||
NetPath Pathway | TSLP Signaling Pathway | |||
TCR Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Pathway Interaction Database | IL12-mediated signaling events | |||
Reactome | Binding and entry of HIV virion | |||
Chemokine receptors bind chemokines | ||||
G alpha (i) signalling events | ||||
WikiPathways | TCR Signaling Pathway | |||
GPCRs, Class A Rhodopsin-like | ||||
HIV Life Cycle | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Benitec Ltd. | |||
REF 2 | Progress on RNAi-based molecular medicines. Int J Nanomedicine. 2012; 7: 3971-3980. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.